Qingqing Yi - Jun 16, 2021 Form 4 Insider Report for BeiGene, Ltd. (BGNE)

Role
Director
Signature
/s/ Qingqing Yi
Stock symbol
BGNE
Transactions as of
Jun 16, 2021
Transactions value $
$0
Form type
4
Date filed
6/24/2021, 12:26 PM
Next filing
Jun 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BGNE Ordinary Shares Award $0 +7.8K $0.00 7.8K Jun 16, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BGNE Share Option (Right to Buy) Award $0 +17.5K $0.00 17.5K Jun 16, 2021 Ordinary Shares 17.5K $26.53 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 16, 2021, subject to continued service. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events.
F2 The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each ADS represents 13 ordinary shares.
F3 These securities vest over a four-year period as follows: 25% on the first anniversary of June 16, 2021 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested shares are subject to accelerated vesting upon change of control or certain termination events.